Annual CFI
-$3.73 M
-$117.80 M-103.27%
31 December 2023
Summary:
Editas Medicine annual cash flow from investing activities is currently -$3.73 million, with the most recent change of -$117.80 million (-103.27%) on 31 December 2023. During the last 3 years, it has risen by +$136.79 million (+97.34%). EDIT annual CFI is now -103.27% below its all-time high of $114.07 million, reached on 31 December 2022.EDIT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$83.98 M
+$32.02 M+61.64%
30 September 2024
Summary:
Editas Medicine quarterly cash flow from investing activities is currently $83.98 million, with the most recent change of +$32.02 million (+61.64%) on 30 September 2024. Over the past year, it has increased by +$186.80 million (+181.68%). EDIT quarterly CFI is now -5.88% below its all-time high of $89.23 million, reached on 30 September 2022.EDIT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$194.03 M
+$186.80 M+2584.02%
30 September 2024
Summary:
Editas Medicine TTM cash flow from investing activities is currently $194.03 million, with the most recent change of +$186.80 million (+2584.02%) on 30 September 2024. Over the past year, it has increased by +$288.13 million (+306.20%). EDIT TTM CFI is now at all-time high.EDIT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDIT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -103.3% | +181.7% | +306.2% |
| 3 y3 years | +97.3% | +311.7% | +238.1% |
| 5 y5 years | +93.0% | +168.7% | +4752.9% |
EDIT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -103.3% | +97.3% | -5.9% | +181.7% | at high | +238.1% |
| 5 y | 5 years | -103.3% | +97.3% | -5.9% | +155.2% | at high | +176.7% |
| alltime | all time | -103.3% | +98.0% | -5.9% | +146.4% | at high | +176.7% |
Editas Medicine Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $83.98 M(+61.6%) | $194.03 M(+2584.0%) |
| June 2024 | - | $51.95 M(-1194.9%) | $7.23 M(-122.8%) |
| Mar 2024 | - | -$4.75 M(-107.6%) | -$31.74 M(+750.8%) |
| Dec 2023 | -$3.73 M(-103.3%) | $62.84 M(-161.1%) | -$3.73 M(-96.0%) |
| Sept 2023 | - | -$102.82 M(-892.0%) | -$94.10 M(-196.1%) |
| June 2023 | - | $12.98 M(-44.2%) | $97.95 M(+21.0%) |
| Mar 2023 | - | $23.27 M(-184.5%) | $80.96 M(-29.0%) |
| Dec 2022 | $114.07 M(-309.4%) | -$27.53 M(-130.9%) | $114.07 M(-3.9%) |
| Sept 2022 | - | $89.23 M(-2329.6%) | $118.76 M(-1272.1%) |
| June 2022 | - | -$4.00 M(-107.1%) | -$10.13 M(+656.7%) |
| Mar 2022 | - | $56.37 M(-346.8%) | -$1.34 M(-97.5%) |
| Dec 2021 | -$54.47 M(-61.2%) | -$22.84 M(-42.4%) | -$54.47 M(-61.2%) |
| Sept 2021 | - | -$39.66 M(-927.8%) | -$140.52 M(-44.5%) |
| June 2021 | - | $4.79 M(+47.7%) | -$253.12 M(+37.8%) |
| Mar 2021 | - | $3.24 M(-103.0%) | -$183.74 M(+30.8%) |
| Dec 2020 | -$140.52 M(-1246.9%) | -$108.89 M(-28.5%) | -$140.52 M(+490.2%) |
| Sept 2020 | - | -$152.26 M(-305.3%) | -$23.81 M(-487.0%) |
| June 2020 | - | $74.17 M(+59.6%) | $6.15 M(-23.9%) |
| Mar 2020 | - | $46.46 M(+494.3%) | $8.09 M(-34.0%) |
| Dec 2019 | $12.25 M | $7.82 M(-106.4%) | $12.25 M(-393.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$122.30 M(-260.7%) | -$4.17 M(-104.0%) |
| June 2019 | - | $76.11 M(+50.3%) | $104.51 M(-341.5%) |
| Mar 2019 | - | $50.63 M(-688.4%) | -$43.28 M(-18.5%) |
| Dec 2018 | -$53.09 M(-71.1%) | -$8.60 M(-36.8%) | -$53.09 M(+198.2%) |
| Sept 2018 | - | -$13.62 M(-81.0%) | -$17.80 M(-46.1%) |
| June 2018 | - | -$71.68 M(-275.6%) | -$33.03 M(-76.8%) |
| Mar 2018 | - | $40.82 M(+53.0%) | -$142.33 M(-22.6%) |
| Dec 2017 | -$183.81 M(+5192.5%) | $26.68 M(-192.5%) | -$183.81 M(-12.3%) |
| Sept 2017 | - | -$28.85 M(-84.1%) | -$209.53 M(+15.5%) |
| June 2017 | - | -$180.99 M(>+9900.0%) | -$181.39 M(>+9900.0%) |
| Mar 2017 | - | -$656.00 K(-168.1%) | -$1.57 M(-54.9%) |
| Dec 2016 | -$3.47 M(+142.7%) | $963.00 K(-235.1%) | -$3.47 M(-28.2%) |
| Sept 2016 | - | -$713.00 K(-38.6%) | -$4.84 M(+12.1%) |
| June 2016 | - | -$1.16 M(-54.7%) | -$4.31 M(+17.0%) |
| Mar 2016 | - | -$2.56 M(+538.9%) | -$3.69 M(+157.7%) |
| Dec 2015 | -$1.43 M(+17.6%) | -$401.00 K(+111.1%) | -$1.43 M(+38.9%) |
| Sept 2015 | - | -$190.00 K(-64.5%) | -$1.03 M(+22.6%) |
| June 2015 | - | -$535.00 K(+75.4%) | -$840.00 K(+175.4%) |
| Mar 2015 | - | -$305.00 K | -$305.00 K |
| Dec 2014 | -$1.22 M | - | - |
FAQ
- What is Editas Medicine annual cash flow from investing activities?
- What is the all time high annual CFI for Editas Medicine?
- What is Editas Medicine annual CFI year-on-year change?
- What is Editas Medicine quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Editas Medicine?
- What is Editas Medicine quarterly CFI year-on-year change?
- What is Editas Medicine TTM cash flow from investing activities?
- What is the all time high TTM CFI for Editas Medicine?
- What is Editas Medicine TTM CFI year-on-year change?
What is Editas Medicine annual cash flow from investing activities?
The current annual CFI of EDIT is -$3.73 M
What is the all time high annual CFI for Editas Medicine?
Editas Medicine all-time high annual cash flow from investing activities is $114.07 M
What is Editas Medicine annual CFI year-on-year change?
Over the past year, EDIT annual cash flow from investing activities has changed by -$117.80 M (-103.27%)
What is Editas Medicine quarterly cash flow from investing activities?
The current quarterly CFI of EDIT is $83.98 M
What is the all time high quarterly CFI for Editas Medicine?
Editas Medicine all-time high quarterly cash flow from investing activities is $89.23 M
What is Editas Medicine quarterly CFI year-on-year change?
Over the past year, EDIT quarterly cash flow from investing activities has changed by +$186.80 M (+181.68%)
What is Editas Medicine TTM cash flow from investing activities?
The current TTM CFI of EDIT is $194.03 M
What is the all time high TTM CFI for Editas Medicine?
Editas Medicine all-time high TTM cash flow from investing activities is $194.03 M
What is Editas Medicine TTM CFI year-on-year change?
Over the past year, EDIT TTM cash flow from investing activities has changed by +$288.13 M (+306.20%)